Lab Automation Market Size, Share, Growth, and Industry Analysis, By Type (Automated Liquid Handling Systems, Microplate Readers, Automated Elisa Systems, Automated Nucleic Acid Purification Systems, Off-the-shelf Automated Workcells, Robotic Systems, Automated Storage & Retrieval Systems (ASRS), Software, Other Equipment) By Application (Drug Discovery, Clinical Diagnostics, Microbiology Solutions, Other Applications) and Regional Forecast to 2033

•   
•   
  

  Request a Free sample to learn more about this report

    

LAB AUTOMATION MARKET OVERVIEW

The global Lab Automation Market, valued at approximately USD 10.3 billion in 2024, is projected to grow steadily to USD 11.18 billion in 2025 and is expected to reach USD 21.42 billion by 2033, maintaining a CAGR of about 8.47% over the forecast period 2025-2033.

The lab automation market is changing the way modern labs operate through efficiencies, reducing errors by humans, and improving the robustness of data collection. The lab automation market engages in a tremendous amount of market verticals (e.g. drug discovery, clinical diagnostics, and microbiology) and automating repetition using software, robotics, and specialized instrumentation. The increasing demand for greater throughput, accuracy, and reproducibility has led to the use of automated liquid handling systems, ELISA automation, and overall companies are continuously invested in modular or scalable systems, both for lab research and routine diagnostics. The increasing pressures on healthcare systems have created a dire need for lab automation to assist with quality control and turn-around times. The changing lab automation market is part of a much larger global awareness of lab evolution toward digital and smart labs.

COVID-19 IMPACT

Lab Automation market Had a Positive Effect Due to Increased Acceptance of Lab Automation During COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing

higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic accelerated the acceptance of lab automation around the world's healthcare and pharmaceutical sectors. Facing greater demand than ever for increase testing, labs had to figure out their way through increased demand and change toward automation, given that they had little labor available. The ability to run automated systems became critical to keeping the lab functioning. Lab automation provided the ability to process samples more rapidly, decreased human testing intervention, and increased testing accuracy, especially in diagnostic (where COVID-19 testing demands were high) labs. As a result of COVID-19, hundreds of public and private laboratories paid for and implemented automated ELISA systems, nucleic acid purification systems, liquid handling systems and other types of laboratory automation systems into their labs at rates never seen globally. Some labs scaled their operations 100's of times their previous maximum capability and capability to operate was dependent on automation, not people. Pandemic operations exposed how vulnerable manual lab operations were for our industry, and drove change makers, investors, and other stakeholders to pursue the strategy of digital transformation. Remote access features of analytic software during lockdown, and the same for data analytics, saw very high successful user ratios, which also certainly counted into some planning decisions around automated labs, as it was better than not completing work. At the end of day, automation is no longer a value-add, it is a necessity to conducting lab work, and engaging lab employees in high quality work to drive human workforce value at a time of disruption.

LATEST TRENDS

Integration of Artificial Intelligence (AI) in Lab Automation to Drive Market Growth

Artificial Intelligence (AI) and machine learning (ML) integration into lab workflows is one of the major trends that is impacting the lab automation market. AI optimizes the performance of instruments and allows for predictive maintenance, more intelligent scheduling, and more advanced analysis of data. The application of these technologies can automate complex decisions and patterns within very high throughput genomics or diagnostics datasets. In terms of research use, AI-driven lab automation for drug discovery streamlines compound screening and enhances reproducibility. In addition, AI tools via the cloud allow for real-time remote viewing, sharing and diagnostic capabilities from virtually anywhere. This trend represents a greater level of automation by making lab automation systems more adaptable, intelligent and user-friendly as a new standard of productivity and efficiency in modern laboratories.

•   
•   
  

  Request a Free sample to learn more about this report

    

LAB AUTOMATION MARKET SEGMENTATION

BY TYPE

Based on Type, the global market can be categorized into Automated Liquid Handling Systems, Microplate Readers, Automated Elisa Systems, Automated Nucleic Acid Purification Systems, Off-the-shelf Automated Workcells, Robotic Systems, Automated Storage & Retrieval Systems (ASRS), Software, Other Equipment:

Automated Liquid Handling Systems: Automated liquid handling systems are an increasingly important part of laboratory workflows in the modern laboratory. Automated liquid handling systems can now automate and provide throughput capacity for standard workflows such as pipetting, dispensing reagents, or preparing samples. They have allowed for different workflows without the added risk and traditional sources of manual error, along with providing throughput capacity. This has led to increased demand for the adoption of automated liquid handling systems in both clinical laboratories and research laboratories alike, where throughput capacity is important. Automated liquid handling systems are very importantly valuable in laboratory applications performing laboratory tasks where precision and consistency are important, for examples PCR preparations and NGS. The value of automated liquid handling systems has risen during the last several years, providing further value and flexibility to the user by supporting a wide range of protocols and labware types. In addition, laboratories have learned that automated systems provide reduced human intervention, greater accuracy, and reproducibility to laboratory workflows. As the merged adoption and transition from manual labor to automated liquid handling systems continues to improve slowly but surely into all scientific disciplines.

Microplate Readers: Microplate Readers are useful instruments that allow detection and quantification of a biological, chemical, or physical reaction while utilizing microwell plates. Microplate Readers could be used for several applications including, enzyme-linked immunosorbent assays (ELISA) protein quantitation and cell viability assays. Microtowell plate systems can provide combinations of sample scaling, requiring fewer wells for an increase in throughput and efficiency, and less variability. The lab had the opportunity to improve sensitivity and efficiency with multiple read modes (absorbance, fluorescence and luminescence) and newer designs with added connectivity and data analytics to make a complete digital lab ecosystem. Microplate readers are reliable workhorses for labs spanning diagnostics, drug discovery and molecular biology, providing flexibility for automation aspects.

Automated ELISA systems: Automated ELISA systems offer the ability to automate the process of immunoassay workflows, which are comprised of many different workflows (reagent addition, development, detection), and increase throughput as well. This is an important aspect of using automated ELISA systems are reproducibility, consistency, and reduced change of contamination. Automated ELISA systems are particularly important in large diagnostic laboratories following screening initiatives for infectious disease. Considering public health emergencies including pandemics, automated ELISA platforms experienced sudden increases in demand, allowing high-throughput antibody/antigen testing. Automated ELISA systems can be utilized as a single format, or in tandem with antibodies or antigens to develop multiplex applications. The various microplate formats that can be used with automated ELISA systems are a distinctive feature of the platform. Therefore, the flexibility and automation of automated ELISA systems can reduce problems associated with humans and offer more robust reproducibility. With the ongoing expansion of diagnostics testing, we will continue to rely on automated ELISA systems to serve our testing requirements.

Automated Nucleic Acid Purification Systems: These systems provide the automated extraction of DNA and RNA from samples - a focused area of molecular diagnostics and research. Automated systems create efficiencies in speed, reproducibility, and biosafety, especially in the context of infectious disease diagnostics, by minimizing the manual handling of specimens. By processing many samples in a timely manner, these systems typically deliver the best solution in those diagnostic laboratories that process large volumes or the best solution in rapid response situations. They are generally thought of in the context of workflows involving PCR, NGS, or genetic testing. Ultimately, the closed-system approach is adopted in laboratories to address risk as it is a contributory hazard leading to contamination. The emphasis on automation and closed-system designs is changing with the incorporation of genomics and personalized medicine which is driving demand to automate sample processing generating the assertion that nucleic acid purification automation is rapidly differentiating itself as the primary option in sample processing for building a molecular lab.

Automated Workcells Off the Shelf: Automated work cells that come off the shelf, provide preconfigured solutions to bring a combination of lab instruments together as one system for easy workflows. These typically have great benefit for labs requiring quick turnaround time without the hassle of custom integration. They often perform tasks such as sample preparation, mixing, incubation, and analysis. They are designed to be modular in appearance to enable a lab to add, modify or upgrade instruments depending on the changing needs of the lab. With more labs adopting a focus to standardize workflows and eliminate manual lab labor, turnkey solutions like these are growing in popularity and utility. The offer a ease in usability, scalability, and simple setup time, while shouldering the burden of lab automation.

Robotic Systems: Robotic systems are changing labs by automating complex, repetitive, and analytical tasks. Robotic systems can be programmed and configured to extend from transporting plates to sorting or preparing an assay. Robotic systems provide consistency, speed, and reduce the need for manual or human effort when integrated into lab automation systems. Where robotic systems should be integrated into lab workflows are with robotic arms which are common in high-throughput screening, genomics, and toxicology. Robotic arms are customizable and can run for as long as you want during the day with little or no human oversight. With research and diagnostics being scaled up, robotic systems are necessary to control efficiency and maintain quality assurance in all types of lab environment.

Automated Storage & Retrieval Systems (ASRS): ASRS assists sample management by automating the storage of biological specimens, and biological material, reagents, consumables, etc. ASRS systems aid in proper inventory management, as well as reducing human touch points to be able to uphold the integrity of temperature-sensitive materials. ASRS systems have been standard practice in biobanks, clinical labs, and pharmaceutical or R& D settings for some time. They work for sample tracking and traceability when interfaced with LIMS (Laboratory Information Management Systems), as they usually have some functionality for integration via API or other methods. They also help reduce the footprint of storage and accessing samples for users at speed. ASRS systems saw greater relevance with the rise of large-scale sample biobanks, repositories and personalized medicine. With the operational cost effectiveness and accuracy in sample logistics, they are changing the way we plan labs and lab infrastructure.

Software: Software contributes significantly to lab automation via connecting hardware systems, orchestrating workflows, and analyzing data. Software systems manage several stages of lab operations from scheduling instruments, pulling data from instruments and reporting, thus ensuring connected operations in the lab. It also manages regulatory activities by maintaining traceability through audit trails, data security, all important in demonstrating compliance. Advancement in data analytics and AI through software tools is also helping researchers develop understanding and optimize experiments. With labs increasingly becoming digital, software is connecting researchers to lab data, enabling remote access and monitoring of experiments using digital twins. As labs experience scaled up activities or become multi-site entities, software represents an opportunity for centralized management across disparate parts of the operation. To sum up, software plays a critical role in lab automation, largely acting as the brain behind automation tools, arrangements, and interactions. That contributes to impact and a growing segment.

Other Equipment: This area reviews the various support pieces of equipment including centrifuges, incubators, heaters, barcode readers and liquid dispensers which all supplement the automation process in laboratory workflows. Often overlooked, support equipment is no less significant than any other part of a complete automation workflow, with the aim of taking each step in the handling of the workflow without interruption. Looking to the future, support equipment is increasingly being fully automated with programmed integration into automation workflow which therefore provide a feedback loop from both a device and data definition standpoint to demonstrate an increasingly intelligent and efficient support equipment in the laboratory. Clearly, as laboratories move to fully automate every incremental touchpoint from specimen retrieval to specimen intake, we would only anticipate additional demand for support equipment to continue to grow and eventually drive demand for a more mature offerings market.

BY APPLICATION

Based on application, the global market can be categorized into Drug Discovery, Clinical Diagnostics, Microbiology Solutions, Other Applications:

Drug Discovery: Lab automation is vital to drug discovery in several areas including high-throughput screening, lead optimization, and compound management. Automated systems mean scientists can be consistent while processing large chemical libraries. Researchers can identify active compounds in a quicker manner. Robotics and liquid handling tools specifically help minimize errors and shorten the turnaround time during repetitive assay processes. Software platforms can also integrate data management and prediction analytics as well. As drug pipelines become more complex and personalized medicine expand, automated lab solutions are scalable to adapt to complex workflows. The level of automation seen in today's labs is transforming how pharmaceutical companies manage their R&D processes (e.g., faster, data-driven).

Clinical Diagnostics: Automated clinical diagnostics are about improving efficiency, reliability, and accuracy in repeated testing processes. Whether it involves the full sample pathway of automated sample handling, or systems for ELISA or nucleic acid testing, automated diagnostics are a means for laboratories to analyze thousands of samples with little human interface. Automation of procedures enables the standardization of protocols, critical for patient safety and to meet compliance with regulations. As it has been shown during a health emergency, automated diagnostics platforms also help limit bottlenecks and improve turnaround time. Software tool integrations can also help support the storage and management of patient data, as well as facilitate tracking of samples. The increased expectation of timely diagnosis and treatment will push laboratories towards or depend on diagnostic systems capable of mass daily deployment to provide high-volume, high-quality, scalable, and consistent diagnostic services across the globe.

Microbiology Solutions: Automation of microbiological methods are largely centered on aspects of microbiology like culturing, staining and counting of colonies which are usually labor-intensive. Various automated platforms help support greater consistency regarding the microbe identified and susceptibility testing which subsequently improves variability with a reduction in manual work. Automated systems even incorporate integrated solutions with plating, incubation, and digital Imaging; therefore, reducing the time to result dramatically. Automated systems will support workflow with major advantages by better processing samples and will like virtually every other field of work be very welcome in clinical microbiology and food safety labs especially with the great emphasis on accuracy, speed, and consistency. As software-enabled imagers can provide images which support analysis algorithms for positive identification and AI-driven interpretation; therefore, traditional methods of identification can be evolved into modern, digital tools. With microbiologists grappling with increased antimicrobial resistance and the demand for rapid microbial detection, automation can increasingly be viewed in microbiology labs to cover purpose.

Other Applications: In addition to drug discovery and diagnostics, lab automation is being used in environmental testing, agriculture, forensic science and academic research. In all of these areas, lab automation improves management of complex experiments, integrity of data and reduces repetitive tasks. In forensic labs for example, automated systems for DNA extractions with chain-of-custody are reducing error rates. Agriculture is where lab automation has been introduced to works like soil testing, genetic analysis, etc. The power of lab automation lies in the ability to standardize different protocols and to amplify volumes of work. Lab automation has the versatility and value for an array of disciplines. As more industries turn to data-driven evidence-based science, automation is enhancing speed, reliability, and reproducibility in all types of laboratories.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.                         

DRIVING FACTORS

Rising Demand for High-Throughput Testing to Boost the Market

A principal catalyst for the growth of the Lab Automation market growth has been the emerging need for high-throughput testing, in both research and clinical scenarios. Laboratories operate under constant pressure to process an ever-growing volume of samples while maintaining the same accuracy and time expectancy. Automated systems offer a dependable solution to this burden by executing repetitive tasks both faster and with improved precision than manual methods. In pharmaceuticals research, this results in faster compound screens, and quicker drug development cycles. In diagnostics, high-throughput platforms assist laboratories in promptly identifying and managing disease detection. As the volume of accurate data continues to grow, automation can assist with scaling, maintaining consistency and operational efficiencies, which makes it a desirable option across industries.

Technological Advancements in Robotics and AI to Expand the Market

The advances with robotics, artificial intelligence (AI), and machine learning have created many exciting opportunities for lab automation systems. Modern robotics systems are more adaptable, smaller, and easier than ever to implement across varying lab settings. With AI algorithms on the market, there are now real-time data analytics, predictive maintenance and smart decision support capabilities, which all have positive realignment of lab protocols and workflows, as they decrease the chances for human error that exists when one performs routine laboratory assignments. The developments surrounding AI, machine learning, and robots have also opened up the possibilities that can be considered for personalization and flexibility when working with varying samples and leading different research methodologies. As research laboratories continue to grow their digital transformation strategies and advancements, they will all use technology to create intelligent, connected, and autonomous laboratory environments. Market momentum is driven by the rapid pace of innovation in the market.

RESTRAINING FACTOR

High Initial Investment and Integration Complexity to Potentially Impede Market Growth

A major limitation of lab automation is the cost for purchase, installation and ongoing maintenance of automated systems. Many labs, particularly from the clinical and academic side of things, most often cannot justify this cost, let alone be assured that any savings will be realized long term. There is also significant complexity and resourcing for integrating existing lab space where the automation will work and any desired software, plus there is often ongoing costs for staff training and customization requirements make the implementation a huge undertaking. These limitations may hinder the commitment of labs to adopt automation, particularly in areas with limited budgets or less developed healthcare systems which limits potential growth potential for the lab automation market in less developed markets.

Expansion of Personalized Medicine and Genomics Research to Create Opportunity for The Product in The Market

Opportunity

There is an exciting opportunity for the (LAB-AUTOMATION) market due to the rapid growth of personalized medicine and genomics research. As labs are faced with massive amounts of genetic data and even more complex workflows, the need for automation will impact reproducibility and throughput. Automated systems can facilitate workflows that include DNA/RNA extraction, sequencing preparation, and management of data and the latter steps in workflows for personalized therapeutic planning. Furthermore, with increased implementation of both biomarkers and genetic profiling for clinical decision making, labs will demand scalable and high-throughput systems. Overall, these trends can result in sustained growth in the level of automation across clinical, academic, and biopharma labs worldwide.

Data Integration and Interoperability Issues Could Be a Potential Challenge for Consumers

Challenge

A common problem in laboratory automation has been the lack of standardized protocols for combining data and enabling interoperability across systems and instrumentation. Most laboratories use instrumentation and equipment from multiple vendors, so any harmonized processes and functions are difficult to establish. The issues that make this difficult involve non-standard formats of data, incompatible or inadequate software, and an inability to connect instruments to each other that leads to lost time and potential mistakes. This is why "smart" labs are not truly smart and continue to struggle with digital transformation and the integration issues. Achieving integration and continuity will involve the participation of the industry, the development of middleware, and the development of open architecture and compatibility standards.

•   
•   
  Request a Free sample to learn more about this report

    

LAB AUTOMATION MARKET REGIONAL INSIGHTS

NORTH AMERICA

North America, especially United States Lab Automation market share has strong healthcare infrastructure, advanced research ecosystem, and early adopters of advanced technologies. As a home to premier pharmaceutical companies, biotech firms and clinical laboratories, this region actively fuels and invests in automation related to laboratory productivity and compliance regulations.  Additionally, federal support for research and development encourages and supports the growth of automated processes in research and education in healthcare institutions. Furthermore, this region can support additional automation with the amount of leading automation vendors in the region which adds accessibility and service. The demand for precision medicine and mass level testing has solidified the region's dominant position in the market.

EUROPE

Europe holds a significant spot in the lab automation market thanks to the abundance of regulatory frameworks, significant academic research, and a steady pharmaceutical industry. The main countries for automation efforts include Germany, the UK, and France, all of which are subject to strict data assurance and quality standards. Laboratories in Europe are automating many processes with simple robotics and artificial intelligence (AI) in many areas, including drug discovery processes and clinical diagnostics. European Union, collaborative research is another element in the importance of the European market. Many countries have limitations on budgets, however, the challenges of digital transformation and the pressure to maximize labor productivity are, perhaps, still opportunities for continued demand for automated systems in European laboratories.

ASIA

Asia is rapidly becoming a key player in the lab automation market as it is quickly developing new to old healthcare infrastructure, growing research funding, and an increasing number of diagnostic laboratories. Countries such as China, Japan, South Korea, and India are all investing into updating lab situations to satisfy the increasing needs of public health and research demands. Both international and local businesses are setting up manufacturing and R&D companies to be able to fulfill the regional demand and cost-effective automation will be of particular interest in developing economies where the need to improve efficiency for labs without a substantial capital investment is apparent. With this continued demand this growth momentum will position Asia to be key future driver to the overall global market.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

The key companies in the lab automation market are developing their own automation industry to enhance their competitive positions in a market that is centered around technology, scalability, and adaptability to end-users. Companies like Danaher, Thermo Fisher, and Roche have improved and developed automation solutions through extensive investments in systems that include the integration of AI-and/or-ML-based applications and modular solutions that include cloud-based platforms for monitoring and control of systems. Other companies like Hamilton Company and Tecan Group are focusing on improving their robotics capability to improve workflows and product yield. Other companies are developing strategic partnerships and investments with research and educational institutions to develop customized solutions based on the needs of genomics and diagnostics. Overall, these actions illustrate the competitive nature of the lab automation market, as well as the focus on minimizing operational costs through technology (automation), scale, and adaptability of end-users.

List of Top Lab Automation Companies

                •             Danaher (U.S.)

                •             Abbott (U.S.)

                •             Brooks Automation (U.S.)

                •             PerkinElmer (U.S.)

                •             Labware (U.S.)

                •             Qiagen (Germany)

                •             LabVantage Solutions (U.S.)

                •             Hamilton Company (U.S.)

                •             Agilent Technologies (U.S.)

                •             Roche (Switzerland)

                •             Biotek Instruments (U.S.)

                •             LabLynx (U.S.)

                •             Siemens Healthineers (Germany)

                •             Eppendorf (Germany)

                •             BioMerieux (France)

                •             Aurora Biomed (Canada)

                •             Becton Dickinson (U.S.)

                •             Tecan Group (Switzerland)

                •             Inpeco (Switzerland)

                •             Thermo Fisher (U.S.)
KEY INDUSTRY DEVELOPMENT

April 2022: Siemens has announced its acquiring Dotmatics to build upon its existing portfolio of scientific research and laboratory automation. Dotmatics has emerged as a leader in the use of cloud-based R&D informatics platforms, which typically consist of services such as data aggregation, analytics and workflow management. The acquisition allows Siemens to continue to build upon its laboratory informatics offerings and provide members of the laboratory ecosystem integrated solutions by combining laboratory hardware with intelligent, data-driven software. It also demonstrates the overall pull of the market towards unified platforms, and aligns with trends such as AI, automation and digital transformation. Overall, this deal makes Siemens a more connected player in comprehensive, end-to-end laboratory automation ecosystems.

REPORT COVERAGE       

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis considers both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth. The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.